ENDRA Life Sciences Inc.
NDRANasdaqCIK 1681682HealthcareFiscal year ends Dec 31
Reports and events: 194 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2019-11-1316:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-19-012843 |
| 2019-08-1616:05 ET | 8-K | 3.01 Delisting notice | 0001654954-19-009726 |
| 2019-08-0816:47 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0001654954-19-009079 |
| 2019-07-2908:40 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-19-008564 |
| 2019-05-2016:29 ET | 8-K | 5.07 Shareholder vote results | 0001654954-19-006338 |
| 2019-05-1417:16 ET | 10-Q | Quarterly reportPeriod 2019-03-31 | 0001654954-19-005939 |
| 2019-04-1516:46 ET | DEF 14A | Proxy statementPeriod 2019-05-16 | 0001213900-19-006402 |
| 2019-03-1117:26 ET | 10-K | Annual reportPeriod 2018-12-31 | 0001654954-19-002560 |
| 2019-03-1116:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-19-002547 |
| 2018-11-1316:38 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-18-012539 |
| 2018-11-0517:23 ET | 10-Q | Quarterly reportPeriod 2018-09-30 | 0001654954-18-012009 |
| 2018-10-1616:05 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-18-011232 |
| 2018-08-1717:01 ET | 8-K | 3.01 Delisting notice | 0001654954-18-009335 |
| 2018-08-1316:02 ET | 10-Q | Quarterly reportPeriod 2018-06-30 | 0001654954-18-008949 |
| 2018-07-1809:39 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-18-007790 |
| 2018-07-0208:31 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-18-007217 |
| 2018-06-1506:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events | 0001654954-18-006687 |
| 2018-05-1516:01 ET | 10-Q | Quarterly reportPeriod 2018-03-31 | 0001654954-18-005414 |
| 2018-05-1016:08 ET | DEF 14A | Proxy statementPeriod 2018-06-12 | 0001213900-18-005842 |
| 2018-04-1316:46 ET | 8-K/A | 5.08 Item not in the standard list | 0001654954-18-003928 |
| 2018-04-1316:45 ET | 10-K/A | Annual report, amendedPeriod 2017-12-31 | 0001654954-18-003926 |
| 2018-03-2916:21 ET | 8-K | 5.08 Item not in the standard list | 0001654954-18-003377 |
| 2018-03-2017:16 ET | 10-K | Annual reportPeriod 2017-12-31 | 0001654954-18-002829 |
| 2018-03-2016:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-18-002825 |
| 2018-02-0509:05 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-18-001062 |
| 2017-11-1508:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-17-010693 |
| 2017-11-1416:20 ET | 10-Q | Quarterly reportPeriod 2017-09-30 | 0001654954-17-010633 |
| 2017-08-0716:25 ET | 10-Q | Quarterly reportPeriod 2017-06-30 | 0001654954-17-007009 |
| 2017-06-2213:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-17-005793 |
| 2017-06-2116:55 ET | 10-Q | Quarterly reportPeriod 2017-03-31 | 0001654954-17-005768 |
| 2017-06-0206:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-17-005285 |
| 2017-05-1216:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001654954-17-004582 |
| 2017-05-0311:28 ET | S-1/A | Registration statement, amended | 0001654954-17-003973 |
| 2017-05-0107:43 ET | S-1/A | Registration statement, amended | 0001654954-17-003822 |
| 2017-04-1416:14 ET | S-1/A | Registration statement, amended | 0001654954-17-003323 |
| 2017-03-2706:03 ET | S-1/A | Registration statement, amended | 0001654954-17-002461 |
| 2017-01-2620:57 ET | S-1/A | Registration statement, amended | 0001654954-17-000494 |
| 2017-01-2317:03 ET | S-1/A | Registration statement, amended | 0001654954-17-000432 |
| 2017-01-2012:08 ET | S-1/A | Registration statement, amended | 0001654954-17-000390 |
| 2016-12-2018:39 ET | S-1/A | Registration statement, amended | 0001654954-16-005006 |
| 2016-12-1917:39 ET | S-1/A | Registration statement, amended | 0001654954-16-004963 |
| 2016-12-1517:27 ET | S-1/A | Registration statement, amended | 0001654954-16-004918 |
| 2016-12-0606:02 ET | S-1/A | Registration statement, amended | 0001654954-16-004599 |
| 2016-11-2121:52 ET | S-1 | Registration statement | 0001654954-16-004197 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 17:03 ET. Listed shows no prices and gives no investment advice.